Since last special meeting held on January 2, AELIP renamed European Association Lipodystrophies and therefore develop its actions beyond our borders.
From now on the company extends its scope in Europe and Latin America, while continuing to champion their purposes among which the momentum of a global register of affected support for the European consortium of lipodystrophy, service information and guidance, and consolidation and support to the research being developed at present.
